VRTX241220C505000
- 4.02
- -3.78-48.46%
Vertex Pharmaceuticals Newsroom
Why Vertex Pharmaceuticals (VRTX) Outpaced the Stock Market Today
Another Week, Another Index Record | Lkive Stock
PepGen Stock Craters 35% on FDA Clinical Hold
Tesla To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Monday
Stifel Maintains Hold on Vertex Pharmaceuticals, Raises Price Target to $494
Vertex Pharmaceuticals Analyst Ratings
Stifel Maintains Vertex Pharmaceuticals(VRTX.US) With Hold Rating, Raises Target Price to $494
Stifel Adjusts Price Target on Vertex Pharmaceuticals to $494 From $490, Maintains Hold Rating
Weekly Buzz: Tech stocks hit high scores on ominous day
Market Mixed on Friday the 13th | Livestock
$100 Invested In This Stock 20 Years Ago Would Be Worth This Much Today
Thursday Ends in Index Declines | Wall Street Today
Market Falls Thursday, Producer Inflation Grows, and Tech Pulls Back From Records | LiveStock
TD Cowen Maintains Vertex Pharmaceuticals(VRTX.US) With Buy Rating, Maintains Target Price $525
TD Cowen Keeps Their Buy Rating on Vertex Pharmaceuticals (VRTX)
Market Climbs on CPI Inflation and Likelihood of Rate Cuts | Livestock
Vertex Pharmaceuticals (VRTX) Falls More Steeply Than Broader Market: What Investors Need to Know
Market Falls Wednesday, but Googles Chip Impresses | WST
10 Health Care Stocks With Whale Alerts In Today's Session
Google's Quantum Chip Might Have Contacted Parallel Universes | Live Stock